Concepedia
Statistics
Publications
44
Citations
1.8K
H-Index
26
Active since
1997
Affiliations
AstraZeneca (United Kingdom)(Current)
Janssen (Belgium)
Simulations Plus (United States)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Roche (Switzerland)
Xavier Pépin is an author at AstraZeneca (United Kingdom) specializing in pharmacy, pharmacokinetics, and pharmacology.
Publications per year
1997–2024
Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets
Xavier Pépin, Talia Flanagan, David Holt et al. · Molecular Pharmaceutics · 2016 · 119 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report
Tycho Heimbach, Sandra Suarez‐Sharp, Maziar Kakhi et al. · The AAPS Journal · 2019 · 104 citations
Pharmacy, Bioengineering, Bioavailability +9
Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective
Arian Emami Riedmaier, Kevin DeMent, James E. Huckle et al. · The AAPS Journal · 2020 · 96 citations · Full text
Modeling the Evolution and Rupture of Pendular Liquid Bridges in the Presence of Large Wetting Hysteresis
Xavier Pépin, Damiano Rossetti, S.M. Iveson et al. · Journal of Colloid and Interface Science · 2000 · 86 citations
Engineering, Materials Science, Mechanical Engineering +14
PBPK Absorption Modeling: Establishing the In Vitro–In Vivo Link—Industry Perspective
Cordula Stillhart, Xavier Pépin, Christophe Tistaert et al. · The AAPS Journal · 2019 · 85 citations
Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +16
1–5 of 44